Skip to content
policyVerified

WHO recommends RTS,S malaria vaccine after foundation-backed trials

On 6 October 2021 WHO recommended the RTS,S malaria vaccine for children in moderate-to-high transmission, after trials the Gates Foundation had heavily funded. In the causal graph this event strengthens Vaccine Accessibility, a driver that strengthens First-dose measles vaccination coverage (global, MCV1) — an improving welfare path.

Sources: [1][2]

Read the full account

On 6 October 2021 WHO recommended the RTS,S malaria vaccine for children in moderate-to-high transmission, after trials the Gates Foundation had heavily funded.

Context

Neighbouring GAVI is the later purchaser. Neighbouring polio 2022 is a different pathogen. He did not write the SAGE opinion as a WHO officer.

GAVI 2000 is neighbouring purchaser architecture. Polio 2022 is neighbouring eradication finance.

Bill Gates was Microsoft CEO until January 2000, chairman until February 2014, then a technical adviser until 2020, and a Gates Foundation co-chair. That is not authorship of every Windows copy, every GAVI dose, or every IRS schedule. Melinda French Gates is a different person. Bill Clinton is PER-000772, a different person. A pledge is not a coverage rate. A docket is not a personality.

Why it matters

The path is vaccine-accessibility and infectious-disease-transmission: a completed WHO malaria-vaccine recommendation after foundation-backed trials is an immunization instrument. A recommendation is not a coverage rate.

Who was responsible

Contribution type and responsibility level for each recorded actor — not sole-author shorthand.

  • Bill Gates

    Person

    Direct responsibility

    responsibility level 0.55 · verified

    His foundation funded trials. GSK made the antigen. WHO recommended. GAVI and ministries later procured. He did not sit as SAGE.

What changed

Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.

    1. FactWHO recommends RTS,S malaria vaccine after foundation-backed trials
    2. strengthensDriverVaccine Accessibility
    3. strengthensIndicators (2)First-dose measles vaccination coverage (global, MCV1)
    Improving path

    impact weight 0.45 · Effect from 6 October 2021 · verified

    A completed WHO malaria-vaccine recommendation is a vaccine-access instrument.

    • First-dose measles vaccination coverage (global, MCV1)

      via Vaccine Accessibility

      Better

      Strengthens · Relationship strength 0.39 (weight 0.45 × strength 0.86)

      Observed

      84% of one-year-olds · 11 below the normal line (2024)

      Worse than normal

      7 readings, 2018–2024: fell from 86.4% of one-year-olds to 84% of one-year-olds.

      Above normal = better

    • Under-five mortality rate (global)

      via Vaccine Accessibility

      Better

      Weakens · Relationship strength 0.33 (weight 0.45 × strength 0.73)

      Observed

      37.4 deaths per 1,000 live births · 12.4 above the normal line (2024)

      Worse than normal

      7 readings, 2018–2024: fell from 40 deaths per 1,000 live births to 37.4 deaths per 1,000 live births.

      Above normal = worse

    1. FactWHO recommends RTS,S malaria vaccine after foundation-backed trials
    2. weakensDriverInfectious-Disease Transmission
    3. weakensIndicators (3)Life expectancy at birth
    Mixed path

    impact weight 0.4 · Effect from 6 October 2021 · verified

    A recommended malaria vaccine is an attempted transmission-and-severe-disease reduction path, with lag.

Evidence

The sources behind this fact and its verification state.

Verified2 sources on file
  1. 1.Reuters — WHO recommends malaria vaccine for childrenReuters · High credibility · verified
  2. 2.WHO recommends groundbreaking malaria vaccine for children at riskWorld Health Organization · High credibility · verified
What the sources establish

World Health Organization carries the official instrument or communique. Reuters records the same dated act independently.

Established: 6 October 2021 WHO RTS,S recommendation after foundation-backed trials, independently reported.

Not established: that malaria died that week, or a unique later child-mortality coefficient from Geneva.

GSK made the antigen. WHO recommended. GAVI and ministries later procured. He did not sit as SAGE.. A later repeal, court stay, or successor order would be a different Fact with a different date. That pair identifies WHO recommends RTS,S malaria vaccine after foundation-backed trials, not a later speech about WHO recommends RTS,S malaria vaccine after foundation-backed trials.

Co-authors and later implementers named in Context remain on the file. If a later repeal, stay, or successor instrument exists, it needs its own date and its own row. The contribution described on this Person row is limited to His foundation funded trials. GSK made the antigen. WHO recommended. GAVI and ministries later procured. He did not sit as SAGE. That limit is the alternative to treating office-holding as authorship of every later series.

Causal path

How this event connects to drivers and indicators in the graph.

  1. ActorBill Gates
  2. contributed toFactWHO recommends RTS,S malaria vaccine after foundation-backed trials
  3. strengthensDrivers (2)Vaccine Accessibility
  4. strengthensIndicatorFirst-dose measles vaccination coverage (global, MCV1)

Cite this page

Factrail. (2026). WHO recommends RTS,S malaria vaccine after foundation-backed trials. Factrail. https://factrail.ai/facts/gates-malaria-rts-2021

https://factrail.ai/facts/gates-malaria-rts-2021

Accessed 16 October 2026.

By the Factrail desk · Method: how we source and score · Last reviewed

Dispute this factNamed here, or represent someone who is? Request a right of reply.